Corcept Therapeutics

Patent cliffs & loss of exclusivity

Corcept Therapeutics develops treatments for metabolic and oncologic disorders.

Company

AngelList URLhttps://angel.co/corcept-therapeutics
CAGE Code6MB68
Legal NameCorcept Therapeutics Incorporated
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/corcept-therapeutics
Fax Number650-327-3218
Full Address149 Commonwealth Drive Menlo Park, CA 94025, USA
LinkedIn URLhttps://www.linkedin.com/company/corcept-therapeutics?trk=top_nav_home

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. KORLYMMIFEPRISTONESmall mol.Aug 2038
  2. LIFYORLI (COPACKAGED)RELACORILANTSmall mol.Dec 2041

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Corcept Therapeutics — patent cliffs & loss of exclusivity | CliffBio